Find a Viewpoint

Antimicrobial Viewpoints are articles in which experts in different areas of antimicrobial resistance share their knowledge and opinions about the current status and the future challenges of this field. You can read our editorial and ethics policies for these articles here

<br>Bioinspired peptides as an alternative strategy for controlling multidrug-resistant bacteria </br><em> – by Octávio Luiz Franco </em>
19 February 2024

Bioinspired peptides as an alternative strategy for controlling multidrug-resistant bacteria – by Octávio Luiz Franco

more
<br>The value of diagnostics in the fight against antimicrobial resistance</br><em> – by Rosanna W. Peeling, David L. Heymann & Debi Boeras </em>
25 January 2024

The value of diagnostics in the fight against antimicrobial resistance – by Rosanna W. Peeling, David L. Heymann & Debi Boeras

more
<br>Sulbactam plus durlobactam: a new addition to antibacterial therapies </br><em> – by Ursula Theuretzbacher </em>
20 December 2023

Sulbactam plus durlobactam: a new addition to antibacterial therapies – by Ursula Theuretzbacher

more
<br>The end of the pipeline is dry: major gaps in the clinical evidence required to inform clinical and country-level appraisal and use of newly approved antibiotics</br><em> – by Benedikt Huttner, Lorenzo Moja & Mike Sharland </em>
13 December 2023

The end of the pipeline is dry: major gaps in the clinical evidence required to inform clinical and country-level appraisal and use of newly ...

more
<br>Plasmid-mediated resistance in the gonococcus and the use of post-exposure prophylaxis to prevent bacterial STIs</br><em> – by Christoph M. Tang, Ann Jerse, Martin C. J. Maiden and William M. Shafer </em>
6 December 2023

Plasmid-mediated resistance in the gonococcus and the use of post-exposure prophylaxis to prevent bacterial STIs – by Christoph M. Tang, ...

more
<br>Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development </br><em> – by Tina Guina and Edward A. Weinstein </em>
29 November 2023

Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development – by Tina Guina and Edward A. Weinstein ...

more

Share

FacebookTwitterLinkedInEmail
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top